{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:13:04Z","timestamp":1780495984470,"version":"3.54.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Extrinsic factors and genetic predisposition contribute to the etiology of sarcoidosis, converging in a phenotype of altered immune response associated with multisystemic inflammatory granulomatous tissue infiltration. Immunological reconstitution after hematopoietic stem cell transplantation (HSCT) may represent a unique window for the pathogenesis of the disease. We describe the incidence, clinicopathological features, and HLA associations of sarcoidosis after HSCT in a single-center cohort of patients, together with data from previously published cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively analyzed clinical characteristics and HLA haplotypes from allogeneic (allo) or autologous (auto) HSCT patients from January 2001 through May 2021 at the University Medicine Goettingen (UMG), and data from previously published cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total number of 19 patients was identified. These included 4 patients from our center (3 allo HSCT and 1 auto HSCT) and 15 patients from the literature review. Thirteen patients had received an allo HSCT, and six patients had received an auto HSCT. Sarcoidosis occurred after a median interval of 20 (after allo HSCT) and 7 (after auto HSCT) months, respectively. The predominant HLA allele associated with sarcoidosis was HLA DRB1*03:01. Sarcoidosis involved the respiratory tract in 15 patients (three unknown, one without pulmonary involvement), and it was associated with graft-versus-host disease in 7 of 13 patients receiving allo HSCT. None of the donors or patients had a history of sarcoidosis before transplantation. Disease manifestations resolved with standard glucocorticoid treatment without long-term sequelae.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Sarcoidosis may occur at low frequency during reconstitution of the immune system after HSCT. HLA allele associations reflect the associations observed in the general population, particularly with DRB1*03:01. Further insights into the interplay between Tcell reconstitution and the development of sarcoidosis could also provide novel approaches to an improved understanding of the pathogenesis in sarcoidosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.746996","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T01:59:33Z","timestamp":1633744773000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations"],"prefix":"10.3389","volume":"12","author":[{"given":"Rebecca Isabel","family":"Wurm-Kuczera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Buentzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Felicitas Leni","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Legler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Jakob","family":"Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hasenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Gerd","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Korsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald Georg","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.03.002","article-title":"Immunopathogenesis of Sarcoidosis","volume":"25","author":"Noor","year":"2007","journal-title":"Clin Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet (Elsevier B.V.)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2012.03.018","article-title":"Pathogenesis of Sarcoidosis","volume":"41","author":"M\u00fcller-Quernheim","year":"2012","journal-title":"La Presse Medicale"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3390\/jcm9082633","article-title":"Current Insights in Genetics of Sarcoidosis: Functional and Clinical Impacts","volume":"9","author":"Calender","year":"2020","journal-title":"J Clin Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq325","article-title":"Sarcoidosis HLA Class II Genotyping Distinguishes Differences of Clinical Phenotype Across Ethnic Groups","volume":"19","author":"Sato","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B6","article-title":"HLA Antigens in Sarcoidosis","volume":"27","author":"Brewerton","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1399-0039.2007.00842.x","article-title":"HLA Class II Amino Acid Epitopes as Susceptibility Markers of Sarcoidosis","volume":"70","author":"Voorter","year":"2007","journal-title":"Tissue Antigens"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000189","article-title":"Granuloma Genes in Sarcoidosis: What Is New","volume":"21","author":"Fischer","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-54612-1","article-title":"A Gene\u2013Environment Interaction Between Smoking and Gene Polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis","volume":"9","author":"Rivera","year":"2019","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2011.03.020","article-title":"Human Leukocyte Antigen-A, -B, and -DRB1 Alleles and Sarcoidosis in Chinese Han Subjects","volume":"72","author":"Zhou","year":"2011","journal-title":"Hum Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.4782","article-title":"HLA-DQB1*0201 A Marker for Good Prognosis in British and Dutch Patients With Sarcoidosis","volume":"27","author":"Sato","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.humimm.2011.10.016","article-title":"HLA-DRB1 Allele Frequencies and C4 Copy Number Variation in Finnish Sarcoidosis Patients and Associations With Disease Prognosis","volume":"73","author":"Wennerstr\u00f6m","year":"2012","journal-title":"Hum Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2014-0227OC","article-title":"Association of HLA-DRB1 With Sarcoidosis Susceptibility and Progression in African Americans","volume":"53","author":"Levin","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am J Hum Genet"},{"key":"B15","article-title":"Incidensen Af Maligne Tumores Hos Sarkoidosepatienter [The Incidence of Malignant Tumors in Patients With Sarcoidosis]","volume":"136","author":"Brincker","year":"1974","journal-title":"Ugeskrift laeger"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3109\/02841869209088273","article-title":"Interpretation of Granulomatous Lesions in Malignancy","volume":"31","author":"Brincker","year":"1992","journal-title":"Acta Oncol (Stockholm Sweden)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1986.199","article-title":"The Sarcoidosis-Lymphoma Syndrome","volume":"54","author":"Brincker","year":"1986","journal-title":"Br J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.2.642","article-title":"Pulmonary Sarcoidosis Following Stem Cell Transplantation: Is it More Than a Chance Occurrence","volume":"126","author":"Bhagat","year":"2004","journal-title":"Chest"},{"key":"B19","first-page":"1","article-title":"European Federation for Immunogenetics Standards for Histocompatibility","volume-title":"EFI standards","year":"2019"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1029","article-title":"Allele Frequency Net Database (AFND) 2020 Update: Gold-Standard Data Classification, Open Access Genotype Data and New Query Tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2017.01.001","article-title":"Aggravation D\u2019une Sarco\u00efdose Apr\u00e8s Autogreffe De Cellules Souches H\u00e9matopo\u00ef\u00e9tiques: Un Effet Paradoxal","volume":"38","author":"Marchal","year":"2017","journal-title":"Rev Medecine Interne"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2012.689854","article-title":"A Case of Sarcoidosis in a Patient With Testicular Cancer Post Stem Cell Transplant","volume":"52","author":"Teo","year":"2013","journal-title":"Acta Oncol"},{"key":"B23","article-title":"Possible Transmission of Sarcoidosis via Allogeneic Bone Marrow Transplantation","volume":"14","author":"Heyll","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703192","article-title":"Granulomatous Pneumonitis Following Bone Marrow Transplantation","volume":"28","author":"Sundar","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702874","article-title":"Case Report Resolution of Sarcoidosis After Allogeneic Bone Marrow Transplantation With Donor Lymphocyte Infusions","volume":"27","author":"Tauro","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.340","article-title":"Donor Cell-Derived Sarcoidosis After Allogeneic BMT","volume":"43","author":"Morita","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705606","article-title":"Sarcoidosis as an Unusual Cause of Hepatic Dysfunction Following Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation [3]","volume":"39","author":"Gooneratne","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.235","article-title":"Sarcoidosis-Associated MHC Ags and the Development of Cutaneous and Nodal Granulomas Following Allogeneic Hematopoietic Cell Transplant","volume":"46","author":"Pukiat","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00136112","article-title":"Sarcoidosis in Donor-Derived Tissues After Haematopoietic Stem Cell Transplantation","volume":"41","author":"Kushima","year":"2013","journal-title":"Eur Respir J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2016.01.008","article-title":"More Immune Dysregulation: Sarcoidosis and Chronic Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant","volume":"2","author":"Manalo","year":"2016","journal-title":"JAAD Case Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2007-970329","article-title":"Sarcoidosis - Immunopathogenetic Concepts","volume":"28","author":"Zissel","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A Concise Review of Pulmonary Sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of Action of Antithymocyte Globulin: T-Cell Depletion and Beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518790391","article-title":"Sarcoidosis Following Alemtuzumab Treatment for Multiple Sclerosis","volume":"24","author":"Willis","year":"2018","journal-title":"Mult Scler"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518771276","article-title":"Acute Sarcoidosis in a Multiple Sclerosis Patient After Alemtuzumab Treatment","volume":"24","author":"Graf","year":"2018","journal-title":"Mult Scler (Houndmills Basingstoke England)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102526","article-title":"Anemia and Sarcoidosis Following Treatment With Alemtuzumab","volume":"46","author":"Love","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518804124","article-title":"Sarcoidosis Following Alemtuzumab Treatment: Autoimmunity Mediated by T Cells and Interferon-\u03b3","volume":"24","author":"Pfeuffer","year":"2018","journal-title":"Mult Scler (Houndmills Basingstoke England)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409056299","article-title":"Sarcoidosis Following Chemotherapy for Hodgkin\u2019s Disease","volume":"13","author":"Merchant","year":"1994","journal-title":"Leukemia Lymphoma"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(86)90002-2","article-title":"Sarcoid Reactions in Malignant Tumours","volume":"13","author":"Brincker","year":"1986","journal-title":"Cancer Treat Rev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-001-0415-6","article-title":"Occurence of Sarcoidosis Subsequent to Chemotherapy for Non-Hodgkin\u2019s Lymphoma: Report of Two Cases","volume":"81","author":"Kornacker","year":"2002","journal-title":"Ann Hematol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.seminhematol.2005.09.001","article-title":"Pathophysiology of Graft-Versus-Host Disease","volume":"43","author":"Ferrara","year":"2006","journal-title":"Semin Hematol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4065\/76.4.407","article-title":"Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation","volume":"76","author":"Porrata","year":"2001","journal-title":"Mayo Clinic Proc"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199502060-00002","article-title":"Immune Recovery After Bone Marrow Transplantation","volume":"2","author":"Lenarsky","year":"1995","journal-title":"Curr Opin Hematol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00457-z","article-title":"T Cell Regeneration After Immunological Injury","volume":"21","author":"Velardi","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2001.01116.x","article-title":"Immunological Mechanisms in Sarcoidosis","volume":"31","author":"Conron","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200201-044OC","article-title":"Idiopathic Pneumonia Syndrome After Syngeneic Bone Marrow Transplant in Mice","volume":"166","author":"Bhalla","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.3.834","article-title":"Induction of Monocyte- and T-Cell-Attracting Chemokines in the Lung During the Generation of Idiopathic Pneumonia Syndrome Following Allogeneic Murine Bone Marrow Transplantation","volume":"96","author":"Panoskaltsis-Mortari","year":"2000","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000027992","article-title":"Biological Basis of the HLA-B8,DR3-Associated Progression of Acquired Immune Deficiency Syndrome","volume":"66","author":"Candore","year":"1998","journal-title":"Pathobiology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2003.11.023","article-title":"T Cell Contributions to the Different Phases of Granuloma Formation","volume":"92","author":"Co","year":"2004","journal-title":"Immunol Lett"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238391","article-title":"Cardiac Sarcoidosis: A Long Term Follow Up Study","volume":"15","author":"Cacoub","year":"2020","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-105569","article-title":"Epidemiologie Und Klinisches Erscheinungsbild Der Sarkoidose TT - Epidemiology and Clinical Presentation of Sarcoidosis","volume":"234","author":"Costabel","year":"2017","journal-title":"Klin Monatsbl Augenheilkd"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.746996\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T01:59:38Z","timestamp":1633744778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.746996\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2021.746996"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.746996","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"article-number":"746996"}}